Jones JP - Search Results

1

CNAD: a potent and specific inhibitor of alcohol dehydrogenase.

Goldstein BM, Li H, Jones JP, Bell JE, Zeidler J, Pankiewicz KW, Watanabe KA. Goldstein BM, et al. Among authors: jones jp. J Med Chem. 1994 Feb 4;37(3):392-9. doi: 10.1021/jm00029a011. J Med Chem. 1994. PMID: 8308865

2

Potent inhibitors of human inosine monophosphate dehydrogenase type II. Fluorine-substituted analogues of thiazole-4-carboxamide adenine dinucleotide.

Zatorski A, Goldstein BM, Colby TD, Jones JP, Pankiewicz KW. Zatorski A, et al. Among authors: jones jp. J Med Chem. 1995 Mar 31;38(7):1098-105. doi: 10.1021/jm00007a007. J Med Chem. 1995. PMID: 7707313

3

Crystallographic studies on the complex behavior of nicotine binding to P450cam (CYP101).

Strickler M, Goldstein BM, Maxfield K, Shireman L, Kim G, Matteson DS, Jones JP. Strickler M, et al. Among authors: jones jp. Biochemistry. 2003 Oct 21;42(41):11943-50. doi: 10.1021/bi034833o. Biochemistry. 2003. PMID: 14556625

4

Benign synthesis of 2-ethylhexanoic acid by cytochrome P450cam: enzymatic, crystallographic, and theoretical studies.

French KJ, Strickler MD, Rock DA, Rock DA, Bennett GA, Wahlstrom JL, Goldstein BM, Jones JP. French KJ, et al. Among authors: jones jp. Biochemistry. 2001 Aug 14;40(32):9532-8. doi: 10.1021/bi010063+. Biochemistry. 2001. PMID: 11583152

5

Active site mutations of cytochrome p450cam alter the binding, coupling, and oxidation of the foreign substrates (R)- and (s)-2-ethylhexanol.

French KJ, Rock DA, Rock DA, Manchester JI, Goldstein BM, Jones JP. French KJ, et al. Among authors: jones jp. Arch Biochem Biophys. 2002 Feb 15;398(2):188-97. doi: 10.1006/abbi.2001.2732. Arch Biochem Biophys. 2002. PMID: 11831849

6

Predicting the rates and regioselectivity of reactions mediated by the P450 superfamily.

Jones JP, Korzekwa KR. Jones JP, et al. Methods Enzymol. 1996;272:326-35. doi: 10.1016/s0076-6879(96)72038-4. Methods Enzymol. 1996. PMID: 8791792 No abstract available.

7

Three-dimensional quantitative structure-activity relationship for inhibitors of cytochrome P4502C9.

Jones JP, He M, Trager WF, Rettie AE. Jones JP, et al. Drug Metab Dispos. 1996 Jan;24(1):1-6. Drug Metab Dispos. 1996. PMID: 8825183 No abstract available.

8

Modeling and synthesis of novel tight-binding inhibitors of cytochrome P450 2C9.

Peng CC, Rushmore T, Crouch GJ, Jones JP. Peng CC, et al. Among authors: jones jp. Bioorg Med Chem. 2008 Apr 1;16(7):4064-74. doi: 10.1016/j.bmc.2008.01.021. Epub 2008 Jan 18. Bioorg Med Chem. 2008. PMID: 18255300

9

Metabolism of 1-fluoro-1,1,2-trichloroethane, 1,2-dichloro-1,1-difluoroethane, and 1,1,1-trifluoro-2-chloroethane.

Yin H, Jones JP, Anders MW. Yin H, et al. Among authors: jones jp. Chem Res Toxicol. 1995 Mar;8(2):262-8. doi: 10.1021/tx00044a012. Chem Res Toxicol. 1995. PMID: 7766810

10

Slow-binding inhibition of carboxylesterase and other serine hydrolases by chlorodifluoroacetaldehyde.

Yin H, Jones JP, Anders MW. Yin H, et al. Among authors: jones jp. Chem Res Toxicol. 1993 Sep-Oct;6(5):630-4. doi: 10.1021/tx00035a007. Chem Res Toxicol. 1993. PMID: 8292740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters